Status quo of hybrid coronary revascularization for multi-vessel coronary artery disease

Ralf E. Harskamp, Zhe Zheng, John H. Alexander, Judson B. Williams, Ying Xian, Michael E. Halkos, J. Matthew Brennan, Robbert J. De Winter, Peter K. Smith, Renato D. Lopes

Research output: Contribution to journalReview articlepeer-review

32 Scopus citations


Hybrid coronary revascularization (HCR) combines bypass grafting of the left anterior descending (LAD) coronary artery with percutaneous coronary intervention (PCI) of non-LAD vessels. HCR has been performed as an alternative to CABG or multi-vessel PCI in thousands of patients since the late 1990s. In this review article, we provide an overview on patient selection, procedural sequence and timing, use of surgical techniques and anti-platelet agents. Additionally, patient recovery, satisfaction, costs and clinical outcomes of individual studies after HCR are evaluated. Future directions are also discussed, including the need for adequately powered randomized trials.

Original languageEnglish (US)
Pages (from-to)2268-2277
Number of pages10
JournalAnnals of Thoracic Surgery
Issue number6
StatePublished - Dec 2013
Externally publishedYes

ASJC Scopus subject areas

  • Surgery
  • Pulmonary and Respiratory Medicine
  • Cardiology and Cardiovascular Medicine


Dive into the research topics of 'Status quo of hybrid coronary revascularization for multi-vessel coronary artery disease'. Together they form a unique fingerprint.

Cite this